Ted C. Nark's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 34,819 Restricted Stock Units done . Disclosure was reported to the exchange on May 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 34,819 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2026 | 34,819 | 325,848 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2026 | 19,824 | 19,824 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 17 Nov 2025 | 50,000 | 291,029 (0%) | 0% | 11.7 | 586,000 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 341,029 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 34,819 | 34,819 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 300,771 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 40,258 | 40,258 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 224,318 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 76,453 | 76,453 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2022 | 80,128 | 80,128 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Ted C. Nark | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 144,190 (0%) | 0% | - | Class A Common Stock |